Maximus (NYSE:MMS) Issues FY 2025 Earnings Guidance

Maximus (NYSE:MMS) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 5.900-6.200 for the period, compared to the consensus estimate of 5.950. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.

Analysts Set New Price Targets

Several brokerages recently issued reports on MMS. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Thursday. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a report on Thursday, January 2nd.

Maximus Price Performance

MMS stock opened at $69.86 on Friday. The stock has a market cap of $3.99 billion, a PE ratio of 15.02 and a beta of 0.72. The stock has a 50-day moving average price of $74.73 and a two-hundred day moving average price of $83.38. Maximus has a 1 year low of $68.30 and a 1 year high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.49 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities analysts forecast that Maximus will post 6.05 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date of this dividend is Friday, February 14th. Maximus’s dividend payout ratio is presently 25.81%.

Insider Activity at Maximus

In other news, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at $484,841.61. This trade represents a 25.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Raymond B. Ruddy bought 3,490 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was bought at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the transaction, the director now owns 112,520 shares of the company’s stock, valued at $8,040,679.20. The trade was a 3.20 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 7,063 shares of company stock valued at $502,017. Corporate insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.